Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial. (Q42993200)
Jump to navigation
Jump to search
scientific article published on 12 June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial. |
scientific article published on 12 June 2013 |
Statements
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial (English)
Stanislas Pol
Josep Mallolas
Hugo Fainboim
Curtis Cooper
Jihad Slim
Carmen Mak
Seth Thompson
Anita Y M Howe
Larissa Wenning
Peter Sklar
Janice Wahl
Wayne Greaves
P05411 study investigators